AI Verdict
AMZN has stronger fundamentals based on our AI analysis.
PCRX vs AMZN Fundamental Comparison
| Metric | PCRX | AMZN |
|---|---|---|
| Revenue | $726.4M | $716.9B |
| Net Income | $7.0M | $77.7B |
| Net Margin | 1.0% | 10.8% |
| ROE | 1.0% | 18.9% |
| ROA | 0.6% | 9.5% |
| Current Ratio | 4.54x | 1.05x |
| Debt/Equity | 0.54x | 0.17x |
| EPS | $0.16 | $7.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PCRX vs AMZN: Frequently Asked Questions
Is PCRX or AMZN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. PCRX is rated HOLD (65% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.
How does PCRX compare to AMZN fundamentally?
Pacira BioSciences, Inc. has ROE of 1.0% vs AMAZON COM INC's 18.9%. Net margins are 1.0% vs 10.8% respectively.
Which stock pays higher dividends, PCRX or AMZN?
PCRX has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PCRX or AMZN for long term?
For long-term investing, consider that PCRX has HOLD rating with 65% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PCRX vs AMZN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PCRX vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.